Nb Health Laboratory

Japanese biopharma developing MAbs therapeutics targeting GCPRs in respiratory diseases, chronic inflammation and central nervous system disorders

placeSapporo, Hokkaido, Japan calendar_todayFounded 2006 language nbhl.co.jp

Innovation

8 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 417 times.

YearFilings
20141
20152
20164
20171
20192
20204
20211
20222
20231
20242
20254
20261

Investor mix

3 investors on record; lead investors include Fast Track Initiative, SMBC Venture Capital.

Investor typeCountShare
Venture capital3100%
Coming soon